Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. DEFA14A Proxy Proxy Materials
  4. DEF 14A Proxy Proxy Statement
  5. UPLOAD Other SEC-generated Letter
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. UPLOAD Other SEC-generated Letter
  8. 4 Open-market sale See "Remarks" below sold 127,244 shares at $11.22 ($1,427,614)
  9. 4 Open-market sale Exec. VP Chief Legal Officer sold 13,930 shares at $10.57 ($147,186)
  10. 4 Option exercise President and CEO acquired 59,701 shares (option exercise)
  11. 4 Option exercise See "Remarks" below acquired 15,920 shares (option exercise)
  12. 4 Open-market sale EVP, North America Commercial sold 19,608 shares at an average $10.56 ($207,091)
  13. 4 Open-market sale EVP, International Markets sold 12,935 shares at $10.58 ($136,909)
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Executive VP, Global R&D sold 9,515 shares at $10.57 ($100,536)
  16. 4 Open-market sale Executive VP Global Operations sold 6,183 shares at $10.58 ($65,443)
  17. 4 Open-market sale EVP Global Marketing&Portfolio sold 6,012 shares at $10.57 ($63,523)
  18. 4 Open-market sale Exec. VP, European Commercial sold 7,513 shares at $10.58 ($79,521)
  19. 4 Open-market sale EVP, North America Commercial sold 15,548 shares at an average $10.85 ($168,631)
  20. 4 Open-market sale EVP, International Markets sold 1,400 shares at $10.88 ($15,231)

Page 31 of 128 · 2,555 filings